Wavera® is an innovative pump technology developed and marketed by the French company AMS R&D. 

Bio-inspired, the Wavera® technology consists in the undulation of a membrane, like the fin of a fish, allowing the propulsion of all types of fluids (pure or charged) for pumps, ventilators and compressors.

The main benefits of this breakthough technology are : high energy efficiency, electric power supply, continuous flow, very low shear stress, self-priming, allowing particles, totally sealed...

AMS R&D is implementing its Wavera® technology in high-potential markets : health, energy, environment, transport, home appliance and consumer devices.


***** STRATEGIC OPPORTUNITY (2018) FOR PUMP MANUFACTURERS ***** 
Want to reach new markets and new customers ? Incorporate a breakthrough technology with multiple benefits into your catalog !
AMS R&D is looking for pump manufacturers for licensing the innovative Wavera® technology for specific applications and territories.
Please contact Erik GUILLEMIN, President of AMS R&D, for more information : erik.guillemin@wavera.tech


***** START-UP MEDTECH : CORWAVE *****
The CorWave Joint Venture, a true MedTech nugget, was founded to apply Wavera® technology to the cardiac application LVAD (Left Ventricular Assist Device). www.corwave.com 

AMS R&D owns the Wavera® and French Pump® brands.
www.wavera.tech

AMS R&D - Wavera® Technology

Org chart

Teams

Offices